Saquinavir for SARS-CoV-2 Antiviral drugs

Since December 2019, a new type of coronavirus (SARS-CoV-2) has begun to spread in China, triggering a large-scale virus infection. Due to the lack of effective treatment, as of early February 2020, this disease has not been effectively controlled. Obviously, the ultra-long cycle of new drug discovery cannot alleviate the current tension, so it is a pragmatic choice to find reliable virus inhibitors from some marketed drugs. Creative Biolabs can provide high-throughput screening (HTS) services to screen a number of potential drug candidates to identify effective drugs to defeat SARS-CoV-2. Based on Saquinavir, we can provide a range of testing services (in vitro and in vivo) to determine whether it can be used as a specific and potent drug candidate for SARS-CoV-2 suppression. Saquinavir for SARS-CoV-2 Antiviral drugs https://sars-cov-2.creative-biolabs.com/saquinavir-fortovase-as-an-antiviral-drug-candidate-for-sars-cov2.htm